Current location - Trademark Inquiry Complete Network - Tian Tian Fund - Introduction and details of Hou Fanfan
Introduction and details of Hou Fanfan

Character Experience In 1996, Hou Fanfan entered Harvard Medical School in the United States and trudged and explored this medical science garden.

She cherished this rare opportunity to learn. She woke up early and spent countless nights in the laboratory. The experiment required human blood cells. In order to speed up the research process, she lost count of how many times she inserted a 50-ml syringe into the laboratory.

own arms.

I usually take a few bites of bread when I'm hungry, drink a few sips of cold water when I'm thirsty, and drink a cup of coffee to refresh myself when I'm sleepy.

She has no time to appreciate the charming exotic scenery and colorful foreign customs. Her only wish is to make maximum use of foreign advanced instruments and experimental conditions, to produce more results quickly, to complete her studies as soon as possible, and to serve the motherland.

Almost all of her time is given to laboratories and libraries, and she spends all of her time attending lectures, giving reports, and conducting academic exchanges.

Sometimes, in order to solve a difficult problem, she tried and tested repeatedly and checked the data without getting tired of it.

Every time I return to my residence, I am often so tired that I feel like I am falling apart and don’t want to move.

If you work hard, you will be rewarded.

After staying in the United States for more than 3 years, she published 4 papers in famous international magazines and gave academic reports at the American Kidney Disease Annual Meeting and the International Kidney Disease Annual Meeting 3 times.

In 1996, he won the "Outstanding Scientific Report Award" of the European Dialysis and Transplantation Society.

In 1997, he won the "Blue Ribbon Award" from the American Society of Nephrology and the "Researcher Award" from the International Society of Nephrology in the same year.

She was promoted from a postdoctoral researcher to a principal researcher, bringing glory to the Chinese people.

Hou Fanfan's outstanding performance has won the attention of international experts.

In 1998, Harvard Medical School and the National Kidney Foundation of Singapore simultaneously issued letters of appointment to her, appointing her as a senior researcher with an annual salary of US$100,000.

In the face of generous treatment, she did not forget her original intention and pursuit, which was to treat more Chinese patients. She resolutely declined high-paying offers from abroad and returned to her motherland with a large number of experimental supplies and materials that she usually bought frugally.

After returning to China, she served as the director of the Military Kidney Disease Center of the First Affiliated Hospital of the First Military Medical University and quickly started a new job.

In 1999, he served as the director of the Institute of Nephrology of the People's Liberation Army (now the Institute of Nephrology of Southern Medical University).

In 2003, it won the title of "Technology Gold Star" from the General Logistics Department of the People's Liberation Army.

In December 2009, he was elected as an academician of the Chinese Academy of Sciences.

In February 2011, she was awarded the honorary title of National March 8th Red Flag Bearer Pacesetter by the All-China Women's Federation.

On September 20, 2011, he won the third National Moral Model Nomination Award.

In 2011, he was selected as a national model of doctor-patient harmony.

In 2012, he was elected as a representative of the 18th National Congress of the Communist Party of China.

In 2012, he was elected as an academician of the National Academy of Sciences of the Developing Countries (TWAS).

Research direction: Through clinical randomized controlled studies, it was first confirmed that angiotensin-converting enzyme inhibitors reduce the risk of late-stage chronic kidney disease developing into end-stage renal failure. The results were cited by some international classic textbooks and promoted the clinical medical community's understanding of such patients.

Improvements in treatment strategies have provided evidence-based medical evidence for improving the efficacy of renal protection and treating cardiovascular complications, and established new methods for preventing and treating major fatal and disabling complications of dialysis.

Through systematic basic research, she discovered new pathogenic molecules such as protein oxidation products that promote the progression of renal lesions and cardiovascular complications, clarified the pathogenesis of dialysis-related amyloidosis, and provided insights into the prevention and treatment of chronic kidney disease and its complications.

new target.

Achievements: He has presided over 1 National Natural Science Foundation key project, 5 general projects, and 3 provincial and ministerial key funds.

He has published 292 papers and has won many awards from international societies such as the International Society of Nephrology and the American Society of Nephrology.

Won 4 first-class and 4 second-class science and technology awards at provincial and ministerial level or above.

Undertaken 14 national, provincial and ministerial level key projects including key projects of the National Natural Science Foundation of China.

He has won two second prizes for National Science and Technology Progress Awards and four first prizes for provincial and ministerial level Science and Technology Progress Awards.

He has won many awards from major international societies.

He has won 2 second-class national scientific and technological progress awards and 4 first-class provincial and ministerial-level scientific and technological progress awards.

Obtained 2 national invention patent authorizations.

He has published 292 papers, won many awards from international societies such as the International Society of Nephrology and the American Society of Nephrology, and won 4 first-class and 4 second-class science and technology awards at the provincial and ministerial level or above.

He has won many awards including the first prize of the Chinese Medical Science and Technology Award (ministerial level) in 2003, the second prize of the National Science and Technology Progress Award in 2004 and 2007.

In 2003, it won the title of "Technology Gold Star" from the General Logistics Department of the People's Liberation Army.

Won the "Ho Leung Ho Lee Award" (2006), the second "Chinese Physician Award" (2005), the seventh "Ding Ying Science and Technology Award" (2004) and the title of "Science and Technology Gold Star" by the General Logistics Department of the People's Liberation Army (2002)

).

The 6th "Top Ten Women of Southern Guangdong" Scientific Research and Innovation After taking up the position of department director, Hou Fanfan felt that the burden on his shoulders was heavier.

She always uses her words and deeds to influence and drive everyone around her, and works in the department 14 hours a day.

She repeatedly warned the general practitioners that as doctors, we should always keep the patient in mind, and we should do anything that can save the patient a penny, even if the patient does not understand, or even if we are wronged, we should do it.